Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO1 pseudogene 28 (MTCO1P28) is a genomic DNA sequence on human chromosome 16p13.3 that is highly homologous to the mitochondrial gene encoding cytochrome c oxidase I (MT-CO1), but it is classified as a pseudogene, meaning it does not produce a functional protein product. Pseudogenes arise from duplication or retrotransposition of genes followed by mutational inactivation. MTCO1P28 therefore does not function as an enzyme, receptor, or structural protein, and is not relevant as a therapeutic or diagnostic target. It is different from the active MT-CO1 gene, which encodes a critical mitochondrial protein involved in the electron transport chain, whereas MTCO1P28 lacks this biological role. There is nothing inherently wrong with the gene name or its sequence; the issue is that it lacks functional relevance as a drug target since it is a pseudogene. Any associations with disease, biochemical function, or drug interactions pertain to the active MT-CO1 gene, not this pseudogene.
None (not an active molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome c oxidase I pseudogene 28 (MTCO1P28).